{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:27:31Z","timestamp":1790767651778,"version":"4.1.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012996","name":"University of Cyprus","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012996","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose of Review<\/jats:title>\n            <jats:p>Cancer-related fatigue (CRF) is a prevalent and debilitating symptom among breast cancer survivors\u200b with a significant adverse impact on quality of life\u200b. This comprehensive review synthesizes the current understanding of CRF\u2019s complex pathophysiology, including the interplay of inflammatory, neuroendocrine, and psychosocial mechanisms\u200b, and evaluates diverse intervention strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent Findings<\/jats:title>\n            <jats:p>Non-pharmacologic approaches (e.g., structured exercise, cognitive-behavioural therapy, mindfulness) have the strongest evidence for alleviating CRF and are emphasized as first-line treatments in oncology guidelines (e.g., ASCO, NCCN, ESMO). In contrast, pharmacologic options such as psychostimulants or bupropion show only modest benefits\u200b, with mixed efficacy and notable side effects\u200b, underscoring their limited role. Comparing oncology-focused guidelines with those for myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) which are psychiatry-focused highlight key differences in management approaches and the need for a unified, multidisciplinary framework across specialties.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Modern multidisciplinary, individualized survivorship care, integrating oncologic, psychosocial, and rehabilitative strategies call for adoption of updated, integrated clinical guidelines to optimally address CRF\u200b. By consolidating evidence and expert recommendations, this review aims to inform and enhance the clinical management of CRF and improve survivorship outcomes for breast cancer survivors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11912-025-01697-9","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T03:35:34Z","timestamp":1749612934000},"page":"883-905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chronic Fatigue in Cancer Survivorship: Psychiatry Versus Oncology or Psychiatry with Oncology?"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3353-5242","authenticated-orcid":false,"given":"Vasilios","family":"Kafetzopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pittaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2535-7279","authenticated-orcid":false,"given":"Georgios","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivi","family":"Moniem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"11A","key":"1697_CR1","first-page":"369","volume":"12","author":"D Cella","year":"1998","unstructured":"Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the management of fatigue. Oncol (Williston Park). 1998;12(11A):369\u201377.","journal-title":"Oncol (Williston Park)"},{"issue":"8","key":"1697_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","volume":"13","author":"AM Berger","year":"2015","unstructured":"Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-Related fatigue, version 2.2015. J Natl Compr Canc Netw. 2015;13(8):1012\u201339. https:\/\/doi.org\/10.6004\/jnccn.2015.0122.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"1697_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/annonc\/mdf082","volume":"13","author":"P Servaes","year":"2002","unstructured":"Servaes P, Verhagen S, Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol. 2002;13(4):589\u201398. https:\/\/doi.org\/10.1093\/annonc\/mdf082.","journal-title":"Ann Oncol"},{"issue":"3","key":"1697_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/cncr.28434","volume":"120","author":"XS Wang","year":"2014","unstructured":"Wang XS, Zhao F, Fisch MJ, O\u2019Mara AM, Cella D, Mendoza TR, et al. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014;120(3):425\u201332. https:\/\/doi.org\/10.1002\/cncr.28434.","journal-title":"Cancer"},{"key":"1697_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpr.2018.05.004","volume":"63","author":"HJG Abrahams","year":"2018","unstructured":"Abrahams HJG, Gielissen MFM, Verhagen C, Knoop H. The relationship of fatigue in breast cancer survivors with quality of life and factors to address in psychological interventions: A systematic review. Clin Psychol Rev. 2018;63:1\u201311. https:\/\/doi.org\/10.1016\/j.cpr.2018.05.004.","journal-title":"Clin Psychol Rev"},{"issue":"6","key":"1697_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/annonc\/mdw099","volume":"27","author":"HJG Abrahams","year":"2016","unstructured":"Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: A meta-analysis involving 12,327 breast cancer survivors. Ann Oncol. 2016;27(6):965\u201374. https:\/\/doi.org\/10.1093\/annonc\/mdw099.","journal-title":"Ann Oncol"},{"issue":"1","key":"1697_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/pon.3581","volume":"24","author":"ME Schmidt","year":"2015","unstructured":"Schmidt ME, Chang-Claude J, Seibold P, Vrieling A, Heinz J, Flesch-Janys D, et al. Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study. Psychooncology. 2015;24(1):40\u20136. https:\/\/doi.org\/10.1002\/pon.3581.","journal-title":"Psychooncology"},{"issue":"9","key":"1697_CR8","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1158\/1078-0432.CCR-05-2398","volume":"12","author":"A Collado-Hidalgo","year":"2006","unstructured":"Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006;12(9):2759\u201366. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-2398.","journal-title":"Clin Cancer Res"},{"key":"1697_CR9","doi-asserted-by":"publisher","first-page":"577001","DOI":"10.1016\/j.jneuroim.2019.577001","volume":"334","author":"RA Cohen","year":"2019","unstructured":"Cohen RA, Gullett JM, Woods AJ, Porges EC, Starkweather A, Jackson-Cook CK, et al. Cytokine-associated fatigue prior to, during, and post-chemotherapy for breast cancer. J Neuroimmunol. 2019;334:577001. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577001.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1697_CR10","first-page":"403","volume":"58","author":"J Illi","year":"2012","unstructured":"Illi J, Miaskowski C, Cooper B, Levine JD, Dunn L, West C, et al. Association between pro-inflammatory cytokine genes and symptom clusters in patients undergoing radiation therapy. Cytokine. 2012;58(2):403\u201310.","journal-title":"Cytokine"},{"issue":"6","key":"1697_CR11","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.bbi.2007.03.008","volume":"21","author":"DM Nance","year":"2007","unstructured":"Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987\u20132007). Brain Behav Immun. 2007;21(6):736\u201345. https:\/\/doi.org\/10.1016\/j.bbi.2007.03.008.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"1697_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/01.psy.0000155666.55034.c6","volume":"67","author":"JE Bower","year":"2005","unstructured":"Bower JE, Ganz PA, Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med. 2005;67(2):277\u201380. https:\/\/doi.org\/10.1097\/01.psy.0000155666.55034.c6.","journal-title":"Psychosom Med"},{"issue":"10","key":"1697_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","volume":"11","author":"JE Bower","year":"2014","unstructured":"Bower JE. Cancer-related fatigue\u2013mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597\u2013609. https:\/\/doi.org\/10.1038\/nrclinonc.2014.127.","journal-title":"Nat Rev Clin Oncol"},{"issue":"32","key":"1697_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/jncimonographs\/lgh027","volume":"32","author":"DP Lawrence","year":"2004","unstructured":"Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;32(32):40\u201350. https:\/\/doi.org\/10.1093\/jncimonographs\/lgh027.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"1697_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/10998004231215777","volume":"26","author":"D Garcia-Gonzalez","year":"2024","unstructured":"Garcia-Gonzalez D, Romero-Elias M, Alvarez-Bustos A, Rosado-Garcia S, Sanchez-Lopez AJ, Cantos B, et al. Cancer-Related fatigue and Circulating biomarkers in breast Cancer survivors. Biol Res Nurs. 2024;26(2):270\u20138. https:\/\/doi.org\/10.1177\/10998004231215777.","journal-title":"Biol Res Nurs"},{"issue":"11","key":"1697_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: Understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754\u201362. https:\/\/doi.org\/10.1038\/nrc3829.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"1697_CR17","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1089\/ars.2011.3965","volume":"15","author":"LA Gilliam","year":"2011","unstructured":"Gilliam LA, St Clair DK. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal. 2011;15(9):2543\u201363. https:\/\/doi.org\/10.1089\/ars.2011.3965.","journal-title":"Antioxid Redox Signal"},{"key":"1697_CR18","doi-asserted-by":"publisher","unstructured":"Fagundes CP, Murray DM, Hwang BS, Gouin JP, Thayer JF, Sollers JJ 3, et al. Sympathetic and parasympathetic activity in cancer-related fatigue: more evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology. 2011;36(8):1137\u201347. https:\/\/doi.org\/10.1016\/j.psyneuen.2011.02.005.","DOI":"10.1016\/j.psyneuen.2011.02.005"},{"issue":"6","key":"1697_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/15402002.2020.1869005","volume":"19","author":"HR Bean","year":"2021","unstructured":"Bean HR, Diggens J, Ftanou M, Weihs KL, Stanton AL, Wiley JF. Insomnia and fatigue symptom trajectories in breast cancer: A longitudinal cohort study. Behav Sleep Med. 2021;19(6):814\u201327. https:\/\/doi.org\/10.1080\/15402002.2020.1869005.","journal-title":"Behav Sleep Med"},{"issue":"3","key":"1697_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1200\/JCO.2001.19.3.895","volume":"19","author":"J Savard","year":"2001","unstructured":"Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19(3):895\u2013908. https:\/\/doi.org\/10.1200\/JCO.2001.19.3.895.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1697_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ddmod.2011.05.001","volume":"8","author":"L Fiorentino","year":"2011","unstructured":"Fiorentino L, Rissling M, Liu L, Ancoli-Israel S. The symptom cluster of sleep, fatigue and depressive symptoms in breast Cancer patients: severity of the problem and treatment options. Drug Discov Today Dis Models. 2011;8(4):167\u201373. https:\/\/doi.org\/10.1016\/j.ddmod.2011.05.001.","journal-title":"Drug Discov Today Dis Models"},{"issue":"5","key":"1697_CR22","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1200\/JCO.1998.16.5.1689","volume":"16","author":"JA Broeckel","year":"1998","unstructured":"Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16(5):1689\u201396. https:\/\/doi.org\/10.1200\/JCO.1998.16.5.1689.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1697_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","volume":"3","author":"KM Mustian","year":"2017","unstructured":"Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, et al. Comparison of pharmaceutical, psychological, and exercise treatments for Cancer-Related fatigue: A Meta-analysis. JAMA Oncol. 2017;3(7):961\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6914.","journal-title":"JAMA Oncol"},{"issue":"13","key":"1697_CR24","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1002\/cam4.2490","volume":"8","author":"LR Feng","year":"2019","unstructured":"Feng LR, Regan J, Shrader JA, Liwang J, Ross A, Kumar S, et al. Cognitive and motor aspects of cancer-related fatigue. Cancer Med. 2019;8(13):5840\u20139. https:\/\/doi.org\/10.1002\/cam4.2490.","journal-title":"Cancer Med"},{"issue":"4","key":"1697_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11682-013-9243-2","volume":"7","author":"KL Pomykala","year":"2013","unstructured":"Pomykala KL, Ganz PA, Bower JE, Kwan L, Castellon SA, Irwin MR. The association between pro-inflammatory cytokines, regional cerebral metabolism, and fatigue in breast cancer. Brain Imaging Behav. 2013;7(4):511\u201323.","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"1697_CR26","first-page":"68","volume":"6","author":"L Capuron","year":"2008","unstructured":"Capuron L, Welberg L, Heim C. Cognitive dysfunction relates to excessive psychomotor slowing and Proinflammatory cytokine release in cancer patients treated with cytokines. Mol Psychiatry. 2008;6(1):68\u201375.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"1697_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/tpj.2009.27","volume":"9","author":"H Landmark-Hoyvik","year":"2009","unstructured":"Landmark-Hoyvik H, Reinertsen KV, Loge JH, Fossa SD, Borresen-Dale AL, Dumeaux V. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J. 2009;9(5):333\u201340. https:\/\/doi.org\/10.1038\/tpj.2009.27.","journal-title":"Pharmacogenomics J"},{"key":"1697_CR28","first-page":"151","volume":"5","author":"O Palesh","year":"2013","unstructured":"Palesh O, Peppone L, Innominato P. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep. 2013;5:151\u20135.","journal-title":"Nat Sci Sleep"},{"issue":"7","key":"1697_CR29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ejca.2005.11.026","volume":"42","author":"G Prue","year":"2006","unstructured":"Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: A critical appraisal. Eur J Cancer. 2006;42(7):846\u201363. https:\/\/doi.org\/10.1016\/j.ejca.2005.11.026.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1697_CR30","doi-asserted-by":"publisher","first-page":"205510292093307","DOI":"10.1177\/2055102920933072","volume":"7","author":"AD Crosswell","year":"2020","unstructured":"Crosswell AD, Lockwood KG. Best practices for stress measurement: how to measure psychological stress in health research. Health Psychol Open. 2020;7(2):2055102920933072.","journal-title":"Health Psychol Open"},{"key":"1697_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-642-04231-7_8","volume":"186","author":"K Schmitz","year":"2011","unstructured":"Schmitz K. Physical activity and breast cancer survivorship. Recent Results Cancer Res. 2011;186:189\u2013215. https:\/\/doi.org\/10.1007\/978-3-642-04231-7_8.","journal-title":"Recent Results Cancer Res"},{"issue":"11","key":"1697_CR32","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/jnci\/djy161","volume":"110","author":"LM Buffart","year":"2018","unstructured":"Buffart LM, Sweegers MG, May AM, Chinapaw MJ, van Vulpen JK, Newton RU, et al. Targeting exercise interventions to patients with Cancer in need: an individual patient data Meta-Analysis. J Natl Cancer Inst. 2018;110(11):1190\u2013200. https:\/\/doi.org\/10.1093\/jnci\/djy161.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1697_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","volume":"31","author":"A Fabi","year":"2020","unstructured":"Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F, et al. Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol. 2020;31(6):713\u201323. https:\/\/doi.org\/10.1016\/j.annonc.2020.02.016.","journal-title":"Ann Oncol"},{"issue":"9\u201310","key":"1697_CR34","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/sj.bjc.6690236","volume":"79","author":"P Stone","year":"1999","unstructured":"Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A\u2019Hern R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999;79(9\u201310):1479\u201386. https:\/\/doi.org\/10.1038\/sj.bjc.6690236.","journal-title":"Br J Cancer"},{"issue":"17","key":"1697_CR35","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","volume":"32","author":"JE Bower","year":"2014","unstructured":"Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American society of clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840\u201350. https:\/\/doi.org\/10.1200\/JCO.2013.53.4495.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1697_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","volume":"18","author":"WJ Gradishar","year":"2020","unstructured":"Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(4):452\u201378. https:\/\/doi.org\/10.6004\/jnccn.2020.0016.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"1697_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1998","unstructured":"Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI): psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1998;39(3):315\u201325.","journal-title":"J Psychosom Res"},{"issue":"8","key":"1697_CR38","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/pon.5151","volume":"28","author":"J Weis","year":"2019","unstructured":"Weis J, Wirtz MA, Tomaszewski KA, Hammerlid E, Arraras JI, Conroy T, et al. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): results from the international psychometric validation. Psychooncology. 2019;28(8):1753\u201361. https:\/\/doi.org\/10.1002\/pon.5151.","journal-title":"Psychooncology"},{"key":"1697_CR39","doi-asserted-by":"publisher","first-page":"1044170","DOI":"10.3389\/fped.2022.1044170","volume":"10","author":"L De Nardi","year":"2022","unstructured":"De Nardi L, Lanzetta MA, Ghirigato E, Barbi E, Gortani G. Approach to the child with fatigue: A focus for the general pediatrician. Front Pediatr. 2022;10:1044170. https:\/\/doi.org\/10.3389\/fped.2022.1044170.","journal-title":"Front Pediatr"},{"issue":"3","key":"1697_CR40","first-page":"919","volume":"25","author":"LH Gerber","year":"2017","unstructured":"Gerber LH, Stout N, McGarvey C. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. 2017;25(3):919\u201327.","journal-title":"Support Care Cancer"},{"issue":"Suppl 1","key":"1697_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.12-S1-4","volume":"12","author":"M Hofman","year":"2007","unstructured":"Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist. 2007;12(Suppl 1):4\u201310. https:\/\/doi.org\/10.1634\/theoncologist.12-S1-4.","journal-title":"Oncologist"},{"issue":"5","key":"1697_CR42","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0885-3924(01)00361-X","volume":"22","author":"P Stone","year":"2001","unstructured":"Stone P, Richards M, Hardy J. Fatigue in patients with breast and prostate cancer undergoing radical radiotherapy. J Pain Symptom Manag. 2001;22(5):1007\u201311.","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"1697_CR43","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/00005768-200105000-00006","volume":"33","author":"AL Schwartz","year":"2001","unstructured":"Schwartz AL, Mori M, Gao R, Nail LM, King ME. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc. 2001;33(5):718\u201323. https:\/\/doi.org\/10.1097\/00005768-200105000-00006.","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"1697_CR44","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1007\/s00262-023-03470-y","volume":"72","author":"CA Egelston","year":"2023","unstructured":"Egelston CA, Guo W, Yost SE, Ge X, Lee JS, Frankel PH, et al. Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer. Cancer Immunol Immunother. 2023;72(9):3013\u201327. https:\/\/doi.org\/10.1007\/s00262-023-03470-y.","journal-title":"Cancer Immunol Immunother"},{"key":"1697_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.breast.2019.06.004","volume":"47","author":"BA Wan","year":"2019","unstructured":"Wan BA, Pidduck W, Zhang L, Nolen A, Drost L, Yee C, et al. Patient-reported fatigue in breast cancer patients receiving radiation therapy. Breast. 2019;47:10\u20135. https:\/\/doi.org\/10.1016\/j.breast.2019.06.004.","journal-title":"Breast"},{"issue":"3","key":"1697_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3322\/caac.21397","volume":"67","author":"H Greenlee","year":"2017","unstructured":"Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67(3):194\u2013232. https:\/\/doi.org\/10.3322\/caac.21397.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1697_CR47","doi-asserted-by":"publisher","first-page":"e67834","DOI":"10.7759\/cureus.67834","volume":"16","author":"B Nakata","year":"2024","unstructured":"Nakata B, Sakimura C, Tendo M, Tsukida T, Hori T, Hirakawa K, et al. Palliative care for patients with breast Cancer in a palliative care unit of a Japanese hospital. Cureus. 2024;16(8):e67834. https:\/\/doi.org\/10.7759\/cureus.67834.","journal-title":"Cureus"},{"issue":"5","key":"1697_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409\u201336. https:\/\/doi.org\/10.3322\/caac.21731.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1697_CR49","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","volume":"34","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer society\/american society of clinical oncology breast Cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611\u201335. https:\/\/doi.org\/10.1200\/JCO.2015.64.3809.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1697_CR50","first-page":"1046","volume":"18","author":"KM Mustian","year":"2020","unstructured":"Mustian KM, Alfano CM, Heckler CE. Comparison of pharmacological, psychological, and exercise treatments for cancer-related fatigue: an update of a 2017 systematic review and meta-analysis. J Natl Compr Canc Netw. 2020;18(8):1046\u201353.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1697_CR51","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12885-015-1291-7","volume":"15","author":"H Cramer","year":"2015","unstructured":"Cramer H, Lange S, Klose P, Paul A, Dobos G. Yoga for breast cancer patients and survivors: A systematic review and meta-analysis. BMC Cancer. 2015;15(1):294. https:\/\/doi.org\/10.1186\/s12885-015-1291-7.","journal-title":"BMC Cancer"},{"issue":"2","key":"1697_CR52","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.3747\/co.25.3883","volume":"25","author":"D Tomlinson","year":"2018","unstructured":"Tomlinson D, Robinson PD, Oberoi S, Cataudella D, Culos-Reed N, Davis H, et al. Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis. Curr Oncol. 2018;25(2):e152\u201367. https:\/\/doi.org\/10.3747\/co.25.3883.","journal-title":"Curr Oncol"},{"issue":"1","key":"1697_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11764-015-0450-2","volume":"10","author":"JM Jones","year":"2016","unstructured":"Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv. 2016;10(1):51\u201361. https:\/\/doi.org\/10.1007\/s11764-015-0450-2.","journal-title":"J Cancer Surviv"},{"key":"1697_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2340\/1651-226X.2024.24156","volume":"63","author":"A Almerud","year":"2024","unstructured":"Almerud A, Frisk G, Klasson C, Bjorkhem-Bergman L. Methylphenidate for treating fatigue in palliative cancer care - effect and side effects in real-world data from a palliative care unit. Acta Oncol. 2024;63:9\u201316. https:\/\/doi.org\/10.2340\/1651-226X.2024.24156.","journal-title":"Acta Oncol"},{"issue":"13","key":"1697_CR55","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1200\/JCO.2005.02.8506","volume":"24","author":"E Bruera","year":"2006","unstructured":"Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2006;24(13):2073\u20138. https:\/\/doi.org\/10.1200\/JCO.2005.02.8506.","journal-title":"J Clin Oncol"},{"key":"1697_CR56","doi-asserted-by":"crossref","unstructured":"Loprinzi CL, Kugler JW, Sloan JA, Phase III. randomized, double-blind, placebo-controlled study of methylphenidate for patients with cancer-related fatigue: North central Cancer treatment group N05C7. J Clin Oncol. 2010;28(23):3673\u20139.","DOI":"10.1200\/JCO.2010.28.1444"},{"issue":"4","key":"1697_CR57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/0269216309102614","volume":"23","author":"A Spathis","year":"2009","unstructured":"Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med. 2009;23(4):325\u201331. https:\/\/doi.org\/10.1177\/0269216309102614.","journal-title":"Palliat Med"},{"issue":"14","key":"1697_CR58","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1002\/cncr.25083","volume":"116","author":"P Jean-Pierre","year":"2010","unstructured":"Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a university of Rochester Cancer center community clinical oncology program research base study. Cancer. 2010;116(14):3513\u201320. https:\/\/doi.org\/10.1002\/cncr.25083.","journal-title":"Cancer"},{"issue":"18","key":"1697_CR59","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1200\/JCO.2013.54.4346","volume":"32","author":"A Spathis","year":"2014","unstructured":"Spathis A, Fife K, Blackhall F, Dutton S, Bahadori R, Wharton R, et al. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol. 2014;32(18):1882\u20138. https:\/\/doi.org\/10.1200\/JCO.2013.54.4346.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1697_CR60","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s12885-016-2761-8","volume":"16","author":"E Pituskin","year":"2016","unstructured":"Pituskin E, Haykowsky M, McNeely M, Mackey J, Chua N, Paterson I. Rationale and design of the multidisciplinary team intervention in cArdio-oNcology study (TITAN). BMC Cancer. 2016;16(1):733. https:\/\/doi.org\/10.1186\/s12885-016-2761-8.","journal-title":"BMC Cancer"},{"key":"1697_CR61","doi-asserted-by":"publisher","first-page":"153473542110380","DOI":"10.1177\/15347354211038008","volume":"20","author":"X Sun","year":"2021","unstructured":"Sun X, Chen Y, Cheung WKW, Wu IXY, Xiao F, Chung VCH. Pharmacological interventions for the management of cancer-related fatigue among cancer survivors: systematic review and meta-analysis. Integr Cancer Ther. 2021;20:15347354211038008.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"1697_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10549-007-9831-1","volume":"112","author":"O Minton","year":"2008","unstructured":"Minton O, Stone P. How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Res Treat. 2008;112(1):5\u201313.","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"1697_CR63","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1200\/JCO.2013.50.0181","volume":"31","author":"PC Stone","year":"2013","unstructured":"Stone PC. Methylphenidate in the management of cancer-related fatigue. J Clin Oncol. 2013;31(19):2372\u20133. https:\/\/doi.org\/10.1200\/JCO.2013.50.0181.","journal-title":"J Clin Oncol"},{"issue":"20","key":"1697_CR64","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1200\/JCO.24.00541","volume":"42","author":"JE Bower","year":"2024","unstructured":"Bower JE, Lacchetti C, Alici Y, Barton DL, Bruner D, Canin BE, et al. Management of fatigue in adult survivors of cancer: ASCO-Society for integrative oncology guideline update. J Clin Oncol. 2024;42(20):2456\u201387. https:\/\/doi.org\/10.1200\/JCO.24.00541.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1697_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11864-020-0707-5","volume":"21","author":"MSY Thong","year":"2020","unstructured":"Thong MSY, van Noorden CJF, Steindorf K, Arndt V. Cancer-Related fatigue: causes and current treatment options. Curr Treat Options Oncol. 2020;21(2):17. https:\/\/doi.org\/10.1007\/s11864-020-0707-5.","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"1697_CR66","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2165\/00003495-199957040-00005","volume":"57","author":"JG Edwards","year":"1999","unstructured":"Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs. 1999;57(4):507\u201333. https:\/\/doi.org\/10.2165\/00003495-199957040-00005.","journal-title":"Drugs"},{"issue":"2","key":"1697_CR67","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/070674370404900209","volume":"49","author":"JL Cullum","year":"2004","unstructured":"Cullum JL, Wojciechowski AE, Pelletier G, Simpson JS. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry. 2004;49(2):139\u201344. https:\/\/doi.org\/10.1177\/070674370404900209.","journal-title":"Can J Psychiatry"},{"issue":"1","key":"1697_CR68","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12885-020-6618-9","volume":"20","author":"E Salehifar","year":"2020","unstructured":"Salehifar E, Azimi S, Janbabai G, Zaboli E, Hendouei N, Saghafi F, et al. Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial. BMC Cancer. 2020;20(1):158. https:\/\/doi.org\/10.1186\/s12885-020-6618-9.","journal-title":"BMC Cancer"},{"issue":"6","key":"1697_CR69","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.22034\/APJCP.2018.19.6.1547","volume":"19","author":"F Ashrafi","year":"2018","unstructured":"Ashrafi F, Mousavi S, Karimi M. Potential role of bupropion sustained release for Cancer-Related fatigue: a Double-Blind, Placebo-Controlled study. Asian Pac J Cancer Prev. 2018;19(6):1547\u201351. https:\/\/doi.org\/10.22034\/APJCP.2018.19.6.1547.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1697_CR70","doi-asserted-by":"publisher","unstructured":"Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, et al. Tamoxifen and antidepressant drug interaction in a cohort of 16,887 breast Cancer survivors. J Natl Cancer Inst. 2016;108(3). https:\/\/doi.org\/10.1093\/jnci\/djv337.","DOI":"10.1093\/jnci\/djv337"},{"key":"1697_CR71","doi-asserted-by":"publisher","first-page":"105976","DOI":"10.1016\/j.cct.2020.105976","volume":"91","author":"HSL Jim","year":"2020","unstructured":"Jim HSL, Hoogland AI, Han HS, Culakova E, Heckler C, Janelsins M, et al. A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: study design and procedures. Contemp Clin Trials. 2020;91:105976. https:\/\/doi.org\/10.1016\/j.cct.2020.105976.","journal-title":"Contemp Clin Trials"},{"issue":"8","key":"1697_CR72","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1634\/theoncologist.2015-0037","volume":"20","author":"F Kronenberg","year":"2015","unstructured":"Kronenberg F, Shani A, Ginsberg G. Efficacy of amantadine in managing cancer-related fatigue: A systematic review and meta-analysis. Oncologist. 2015;20(8):876\u201385. https:\/\/doi.org\/10.1634\/theoncologist.2015-0037.","journal-title":"Oncologist"},{"issue":"1","key":"1697_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13063-024-08078-w","volume":"25","author":"M Miladinia","year":"2024","unstructured":"Miladinia M, Jahangiri M, White SJ, Karimpourian H, Inno A, Chan SW, et al. 5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment. Trials. 2024;25(1):230. https:\/\/doi.org\/10.1186\/s13063-024-08078-w.","journal-title":"Trials"},{"issue":"1","key":"1697_CR74","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/spcare-2022-003815","volume":"13","author":"R Chow","year":"2023","unstructured":"Chow R, Novosel M, So OW, Bellampalli S, Xiang J, Boldt G, et al. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. BMJ Support Palliat Care. 2023;13(1):27\u201334. https:\/\/doi.org\/10.1136\/spcare-2022-003815.","journal-title":"BMJ Support Palliat Care"},{"issue":"6","key":"1697_CR75","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00520-012-1694-5","volume":"21","author":"S Yennurajalingam","year":"2013","unstructured":"Yennurajalingam S, Palmer JL, Zhang T, Poulter V, Bruera E, Currow DC. Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer. 2013;21(6):1585\u201391. https:\/\/doi.org\/10.1007\/s00520-012-1694-5.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1697_CR76","doi-asserted-by":"publisher","first-page":"CD010756","DOI":"10.1002\/14651858.CD010756.pub2","volume":"2015","author":"A Haywood","year":"2015","unstructured":"Haywood A, Good P, Khan S, Leupp A, Jenkins-Marsh S, Rickett K, et al. Corticosteroids for the management of cancer-related pain in adults. Cochrane Database Syst Rev. 2015;2015(4):CD010756. https:\/\/doi.org\/10.1002\/14651858.CD010756.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1697_CR77","unstructured":"National Comprehensive Cancer N, American Cancer S. Cancer-related fatigue: practice guidelines for the management of fatigue. Clinical Practice Guidelines in Oncology2005."},{"issue":"12","key":"1697_CR78","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1200\/JCO.2005.04.2838","volume":"24","author":"JP Monk","year":"2006","unstructured":"Monk JP, Phillips G, Waite R, Kuhn J, Schaaf LJ, Otterson GA, et al. Assessment of tumor necrosis factor alpha Blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol. 2006;24(12):1852\u20139. https:\/\/doi.org\/10.1200\/JCO.2005.04.2838.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1697_CR79","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1152\/ajpendo.00105.2023","volume":"325","author":"X Zhang","year":"2023","unstructured":"Zhang X, Lee WD, Leitner BP, Zhu W, Fosam A, Li Z, et al. Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma. Am J Physiol Endocrinol Metab. 2023;325(4):E363\u201375. https:\/\/doi.org\/10.1152\/ajpendo.00105.2023.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"31","key":"1697_CR80","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1200\/JCO.2011.40.2180","volume":"30","author":"RA Cruciani","year":"2012","unstructured":"Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ. L-carnitine supplementation for the management of fatigue in patients with cancer: an Eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2012;30(31):3864\u20139. https:\/\/doi.org\/10.1200\/JCO.2011.40.2180.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1697_CR81","first-page":"461","volume":"27","author":"T Ng","year":"2019","unstructured":"Ng T, Kenny K, Yardley J, Marfan H. Evaluating the role of vitamin D in cancer-related fatigue in breast cancer survivors: A randomized controlled trial. Support Care Cancer. 2019;27(2):461\u20138.","journal-title":"Support Care Cancer"},{"issue":"16","key":"1697_CR82","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/jnci\/djt181","volume":"105","author":"DL Barton","year":"2013","unstructured":"Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, et al. Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013;105(16):1230\u20138. https:\/\/doi.org\/10.1093\/jnci\/djt181.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1697_CR83","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/NCC.0000000000001068","volume":"46","author":"WT Luo","year":"2023","unstructured":"Luo WT, Huang TW. Effects of ginseng on Cancer-Related fatigue: A systematic review and Meta-analysis of randomized controlled trials. Cancer Nurs. 2023;46(2):120\u20137. https:\/\/doi.org\/10.1097\/NCC.0000000000001068.","journal-title":"Cancer Nurs"},{"issue":"9","key":"1697_CR84","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.6004\/jnccn.2017.0149","volume":"15","author":"S Yennurajalingam","year":"2017","unstructured":"Yennurajalingam S, Tannir NM, Williams JL, Lu Z, Hess KR, Frisbee-Hume S, et al. A Double-Blind, randomized, Placebo-Controlled trial of Panax Ginseng for Cancer-Related fatigue in patients with advanced Cancer. J Natl Compr Canc Netw. 2017;15(9):1111\u201320. https:\/\/doi.org\/10.6004\/jnccn.2017.0149.","journal-title":"J Natl Compr Canc Netw"},{"key":"1697_CR85","doi-asserted-by":"publisher","unstructured":"Yennurajalingam S, Lu Z, Rozman De Moraes A, Tull NN, Kubiak MJ, Geng Y, et al. Meta-Analysis of pharmacological, nutraceutical and phytopharmaceutical interventions for the treatment of Cancer related fatigue. Cancers (Basel). 2022;15(1). https:\/\/doi.org\/10.3390\/cancers15010091.","DOI":"10.3390\/cancers15010091"},{"issue":"5","key":"1697_CR86","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/00130404-200609000-00012","volume":"12","author":"CM Alfano","year":"2006","unstructured":"Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006;12(5):432\u201343. https:\/\/doi.org\/10.1097\/00130404-200609000-00012.","journal-title":"Cancer J"},{"issue":"2","key":"1697_CR87","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10549-006-9447-x","volume":"105","author":"M Groenvold","year":"2007","unstructured":"Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007;105(2):209\u201319. https:\/\/doi.org\/10.1007\/s10549-006-9447-x.","journal-title":"Breast Cancer Res Treat"},{"key":"1697_CR88","doi-asserted-by":"publisher","unstructured":"Grach SL, Seltzer J, Chon TY, Ganesh R. Diagnosis and Management of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Mayo Clin Proc. 2023;98(10):1544-51. https:\/\/doi.org\/10.1016\/j.mayocp.2023.07.032","DOI":"10.1016\/j.mayocp.2023.07.032"},{"key":"1697_CR89","doi-asserted-by":"publisher","unstructured":"Nacul L, Authier FJ, Scheibenbogen C, Lorusso L, Helland IB, Martin JA, et al. European network on myalgic encephalomyelitis\/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME\/CFS in Europe. Med (Kaunas). 2021;57(5). https:\/\/doi.org\/10.3390\/medicina57050510.","DOI":"10.3390\/medicina57050510"},{"issue":"7","key":"1697_CR90","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/jnnp-2023-332731","volume":"95","author":"PW Barry","year":"2024","unstructured":"Barry PW, Kelley K, Tan T, Finlay I. NICE guideline on ME\/CFS: robust advice based on a thorough review of the evidence. J Neurol Neurosurg Psychiatry. 2024;95(7):671\u20134. https:\/\/doi.org\/10.1136\/jnnp-2023-332731.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1697_CR91","volume-title":"Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: redefining an illness","author":"Institute of M","year":"2015","unstructured":"Institute of M. Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: redefining an illness. Washington, DC: National Academies; 2015."},{"issue":"11","key":"1697_CR92","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2015.1346","volume":"313","author":"EW Clayton","year":"2015","unstructured":"Clayton EW. Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101\u20132. https:\/\/doi.org\/10.1001\/jama.2015.1346.","journal-title":"JAMA"},{"issue":"11","key":"1697_CR93","doi-asserted-by":"publisher","first-page":"103452","DOI":"10.1016\/j.autrev.2023.103452","volume":"22","author":"S Steiner","year":"2023","unstructured":"Steiner S, Fehrer A, Hoheisel F, Schoening S, Aschenbrenner A, Babel N, et al. Understanding, diagnosing, and treating myalgic encephalomyelitis\/chronic fatigue syndrome - State of the art: report of the 2nd international meeting at the Charite fatigue center. Autoimmun Rev. 2023;22(11):103452. https:\/\/doi.org\/10.1016\/j.autrev.2023.103452.","journal-title":"Autoimmun Rev"},{"key":"1697_CR94","doi-asserted-by":"publisher","unstructured":"Kingdon C, Lowe A, Shepherd C, Nacul L. What primary care practitioners need to know about the new NICE guideline for myalgic encephalomyelitis\/chronic fatigue syndrome in adults. Healthc (Basel). 2022;10(12). https:\/\/doi.org\/10.3390\/healthcare10122438.","DOI":"10.3390\/healthcare10122438"},{"issue":"10","key":"1697_CR95","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s00520-018-4318-7","volume":"26","author":"CM O\u2019Higgins","year":"2018","unstructured":"O\u2019Higgins CM, Brady B, O\u2019Connor B, Walsh D, Reilly RB. The pathophysiology of cancer-related fatigue: current controversies. Support Care Cancer. 2018;26(10):3353\u201364. https:\/\/doi.org\/10.1007\/s00520-018-4318-7.","journal-title":"Support Care Cancer"},{"key":"1697_CR96","doi-asserted-by":"publisher","unstructured":"Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis\/chronic fatigue syndrome: A comprehensive review. Diagnostics (Basel). 2019;9(3). https:\/\/doi.org\/10.3390\/diagnostics9030091.","DOI":"10.3390\/diagnostics9030091"},{"issue":"7","key":"1697_CR97","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1158\/1055-9965.EPI-04-0703","volume":"14","author":"KH Schmitz","year":"2010","unstructured":"Schmitz KH, Holtzman J, Courneya KS. Controlled physical activity trials in cancer survivors: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;14(7):1588\u201395.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"1697_CR98","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1097\/00005768-200212000-00001","volume":"34","author":"TR Burnham","year":"2002","unstructured":"Burnham TR, Wilcox A. Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc. 2002;34(12):1863\u20137. https:\/\/doi.org\/10.1097\/00005768-200212000-00001.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"1697_CR99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1055-9965.EPI-11-0634","volume":"21","author":"SI Mishra","year":"2012","unstructured":"Mishra SI, Scherer RW, Snyder C, Geigle P, Gotay C. Exercise interventions on health-related quality of life for cancer survivors: Meta-analysis of randomized controlled trials. Cancer Epidemiol Biomarkers Prev. 2012;21(1):3\u201319.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1697_CR100","doi-asserted-by":"publisher","unstructured":"Pheby DFH, Friedman KJ, Murovska M, Zalewski P. Turning a corner in ME\/CFS research. Med (Kaunas). 2021;57(10). https:\/\/doi.org\/10.3390\/medicina57101012.","DOI":"10.3390\/medicina57101012"},{"issue":"6 Suppl","key":"1697_CR101","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1188\/14.CJON.S3.38-58","volume":"18","author":"SA Mitchell","year":"2014","unstructured":"Mitchell SA, Beck SL, Hood LE, Moore K, Tanner ER. Putting evidence into practice: an update of evidence-based interventions for cancer-related fatigue during and following treatment. Clin J Oncol Nurs. 2014;18(6 Suppl):38\u201358.","journal-title":"Clin J Oncol Nurs"},{"key":"1697_CR102","doi-asserted-by":"publisher","unstructured":"Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D, Fibromyalgia. Pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021;22(8). https:\/\/doi.org\/10.3390\/ijms22083891.","DOI":"10.3390\/ijms22083891"},{"issue":"27","key":"1697_CR103","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","volume":"34","author":"JA Paice","year":"2016","unstructured":"Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, et al. Management of chronic pain in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(27):3325\u201345. https:\/\/doi.org\/10.1200\/JCO.2016.68.5206.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1697_CR104","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jamaoncol.2021.5948","volume":"8","author":"AB Porter","year":"2022","unstructured":"Porter AB, Liu H, Kohli S, Cerhan JL, Sloan J, McMurray RP, et al. Efficacy of treatment with Armodafinil for Cancer-Related fatigue in patients with High-grade glioma: A phase 3 randomized clinical trial. JAMA Oncol. 2022;8(2):259\u201367. https:\/\/doi.org\/10.1001\/jamaoncol.2021.5948.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1697_CR105","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/17843286.2016.1200816","volume":"71","author":"D Blockmans","year":"2016","unstructured":"Blockmans D, Persoons P. Long-term methylphenidate intake in chronic fatigue syndrome. Acta Clin Belg. 2016;71(6):407\u201314. https:\/\/doi.org\/10.1080\/17843286.2016.1200816.","journal-title":"Acta Clin Belg"},{"issue":"11","key":"1697_CR106","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00103-024-03951-0","volume":"67","author":"J Weis","year":"2024","unstructured":"Weis J. [Fatigue in chronic physical diseases]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024;67(11):1231\u20138. https:\/\/doi.org\/10.1007\/s00103-024-03951-0.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"2","key":"1697_CR107","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1634\/theoncologist.2019-0184","volume":"25","author":"RE Hill","year":"2020","unstructured":"Hill RE, Wakefield CE, Cohn RJ, Fardell JE, Brierley ME, Kothe E, et al. Survivorship care plans in cancer: A Meta-Analysis and systematic review of care plan outcomes. Oncologist. 2020;25(2):e351\u201372. https:\/\/doi.org\/10.1634\/theoncologist.2019-0184.","journal-title":"Oncologist"},{"issue":"4","key":"1697_CR108","first-page":"469","volume":"51","author":"KA Donovan","year":"2017","unstructured":"Donovan KA, Gonzalez BD, Small BJ, Andrykowski MA, Jacobsen PB, Zachariae R. Depressive symptom trajectories during and after adjuvant treatment for breast cancer. Ann Behav Med. 2017;51(4):469\u201379.","journal-title":"Ann Behav Med"},{"issue":"2","key":"1697_CR109","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jpainsymman.2020.02.012","volume":"60","author":"R Twomey","year":"2020","unstructured":"Twomey R, Yeung ST, Wrightson JG, Millet GY, Culos-Reed SN. Post-exertional malaise in people with chronic Cancer-Related fatigue. J Pain Symptom Manag. 2020;60(2):407\u201316. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.02.012.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"1697_CR110","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12028-020-00977-5","volume":"33","author":"DJ Gagnon","year":"2020","unstructured":"Gagnon DJ, Leclerc AM, Riker RR, Brown CS, May T, Nocella K, et al. Amantadine and modafinil as neurostimulants during Post-stroke care: A systematic review. Neurocrit Care. 2020;33(1):283\u201397. https:\/\/doi.org\/10.1007\/s12028-020-00977-5.","journal-title":"Neurocrit Care"},{"issue":"1","key":"1697_CR111","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1474-4422(20)30354-9","volume":"20","author":"B Nourbakhsh","year":"2021","unstructured":"Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, et al. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol. 2021;20(1):38\u201348. https:\/\/doi.org\/10.1016\/S1474-4422(20)30354-9.","journal-title":"Lancet Neurol"},{"issue":"8","key":"1697_CR112","doi-asserted-by":"publisher","first-page":"719","DOI":"10.18632\/oncotarget.27946","volume":"12","author":"M Azeem Khan","year":"2021","unstructured":"Azeem Khan M, Florou V, Swami U. Immunotherapy and fatigue: what we know and what we don\u2019t know. Oncotarget. 2021;12(8):719\u201320. https:\/\/doi.org\/10.18632\/oncotarget.27946.","journal-title":"Oncotarget"},{"issue":"8","key":"1697_CR113","first-page":"2229","volume":"23","author":"LN Saligan","year":"2015","unstructured":"Saligan LN, Kim HS, Wang D. Genetic variation and fatigue in breast cancer survivors. Support Care Cancer. 2015;23(8):2229\u201337.","journal-title":"Support Care Cancer"},{"issue":"5","key":"1697_CR114","first-page":"611","volume":"46","author":"CC Reyes-Gibby","year":"2013","unstructured":"Reyes-Gibby CC, Wang J, Spitz M. Genetic variations in Interleukin 6 and fatigue in patients with breast cancer (Brief report). J Pain Symptom Manag. 2013;46(5):611\u20138.","journal-title":"J Pain Symptom Manag"},{"key":"1697_CR115","unstructured":"A Study of Cancer Related Fatigue in Patients With Metastatic. Cancer Receiving Anti-PD1 Immunotherapy [database on the Internet]2018. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03525873. Accessed."},{"key":"1697_CR116","unstructured":"A Combination Therapy to Treat Cancer-Related Fatigue. - NCI R01 [database on the Internet]2018. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03772834. Accessed."},{"issue":"12","key":"1697_CR117","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1200\/JCO.2011.36.4109","volume":"30","author":"CM Alfano","year":"2012","unstructured":"Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Smith AW, Meeske K, et al. Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors. J Clin Oncol. 2012;30(12):1280\u20137. https:\/\/doi.org\/10.1200\/JCO.2011.36.4109.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1697_CR118","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/jcsm.13435","volume":"15","author":"JD Groarke","year":"2024","unstructured":"Groarke JD, Crawford J, Collins SM, Lubaczewski SL, Breen DM, Harrington MA, et al. Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design. J Cachexia Sarcopenia Muscle. 2024;15(3):1054\u201361. https:\/\/doi.org\/10.1002\/jcsm.13435.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"1697_CR119","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10549-012-2335-7","volume":"137","author":"LJ Peppone","year":"2013","unstructured":"Peppone LJ, Mustian KM, Morrow GR. The effect of YOCAS\u00a9\u00a9 yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy. Breast Cancer Res Treat. 2013;137(2):617\u201328.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"1697_CR120","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1200\/JCO.2013.51.8860","volume":"32","author":"JK Kiecolt-Glaser","year":"2014","unstructured":"Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, et al. Yoga\u2019s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32(10):1040\u20139. https:\/\/doi.org\/10.1200\/JCO.2013.51.8860.","journal-title":"J Clin Oncol"},{"issue":"17","key":"1697_CR121","first-page":"194","volume":"35","author":"HJG Abrahams","year":"2017","unstructured":"Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Bleijenberg G. The efficacy of Internet-based cognitive behavioral therapy for severely fatigued survivors of breast cancer compared with care as usual: A randomized controlled trial. J Clin Oncol. 2017;35(17):194\u2013204.","journal-title":"J Clin Oncol"},{"issue":"31","key":"1697_CR122","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1200\/JCO.19.00572","volume":"37","author":"NM Tauber","year":"2019","unstructured":"Tauber NM, O\u2019Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of Cancer recurrence: A systematic review and Meta-Analysis. J Clin Oncol. 2019;37(31):2899\u2013915. https:\/\/doi.org\/10.1200\/JCO.19.00572.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1697_CR123","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3238\/arztebl.2012.0161","volume":"109","author":"M Horneber","year":"2012","unstructured":"Horneber M, Fischer I, Dimeo F, Ruffer JU, Weis J. Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int. 2012;109(9):161\u201371. https:\/\/doi.org\/10.3238\/arztebl.2012.0161. quiz 72.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"1697_CR124","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1113\/JP286231","volume":"602","author":"NLM LeGood","year":"2024","unstructured":"LeGood NLM, Li X, Ha M, Downer JDR. Prehab? Rehab? Both? Exploring interventions to alleviate disuse-induced muscle atrophy and anabolic resistance in older adults. J Physiol. 2024;602(6):995\u20136. https:\/\/doi.org\/10.1113\/JP286231.","journal-title":"J Physiol"},{"issue":"1","key":"1697_CR125","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11764-017-0641-0","volume":"12","author":"MSY Thong","year":"2018","unstructured":"Thong MSY, Mols F, van de Poll-Franse LV, Sprangers MAG, van der Rijt CCD, Barsevick AM, et al. Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry. J Cancer Surviv. 2018;12(1):38\u201346. https:\/\/doi.org\/10.1007\/s11764-017-0641-0.","journal-title":"J Cancer Surviv"},{"issue":"8","key":"1697_CR126","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/sleep\/33.8.1027","volume":"33","author":"S Bodenmann","year":"2010","unstructured":"Bodenmann S, Landolt HP. Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep. 2010;33(8):1027\u201335. https:\/\/doi.org\/10.1093\/sleep\/33.8.1027.","journal-title":"Sleep"},{"key":"1697_CR127","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbi.2013.11.003","volume":"37","author":"KB Weymann","year":"2014","unstructured":"Weymann KB, Wood LJ, Zhu X, Marks DL. A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun. 2014;37:84\u201394. https:\/\/doi.org\/10.1016\/j.bbi.2013.11.003.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"1697_CR128","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/00325481.2022.2049553","volume":"134","author":"C Chepke","year":"2022","unstructured":"Chepke C, Jain R, Rosenberg R, Moline M, Yardley J, Pinner K, et al. Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder. Postgrad Med. 2022;134(3):316\u201325. https:\/\/doi.org\/10.1080\/00325481.2022.2049553.","journal-title":"Postgrad Med"},{"key":"1697_CR129","doi-asserted-by":"publisher","first-page":"105465","DOI":"10.1016\/j.phrs.2021.105465","volume":"165","author":"PL Toogood","year":"2021","unstructured":"Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): where will the drugs come from? Pharmacol Res. 2021;165:105465. https:\/\/doi.org\/10.1016\/j.phrs.2021.105465.","journal-title":"Pharmacol Res"},{"issue":"23","key":"1697_CR130","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1002\/cncr.27613","volume":"118","author":"PJ de Raaf","year":"2012","unstructured":"de Raaf PJ, Sleijfer S, Lamers CH, Jager A, Gratama JW, van der Rijt CC. Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study. Cancer. 2012;118(23):6005\u201311. https:\/\/doi.org\/10.1002\/cncr.27613.","journal-title":"Cancer"},{"issue":"3","key":"1697_CR131","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/cncr.31790","volume":"125","author":"JE Bower","year":"2019","unstructured":"Bower JE. The role of neuro-immune interactions in cancer-related fatigue: biobehavioral risk factors and mechanisms. Cancer. 2019;125(3):353\u201364. https:\/\/doi.org\/10.1002\/cncr.31790.","journal-title":"Cancer"},{"issue":"3","key":"1697_CR132","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/0898264312468601","volume":"25","author":"T Pudrovska","year":"2013","unstructured":"Pudrovska T, Anishkin A. Early-life socioeconomic status and physical activity in later life: evidence from structural equation models. J Aging Health. 2013;25(3):383\u2013404. https:\/\/doi.org\/10.1177\/0898264312468601.","journal-title":"J Aging Health"},{"issue":"6 Suppl","key":"1697_CR133","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/1097-0142(20010915)92:6+<1689::aid-cncr1498>3.0.co;2-h","volume":"92","author":"FC Dimeo","year":"2001","unstructured":"Dimeo FC. Effects of exercise on cancer-related fatigue. Cancer. 2001;92(6 Suppl):1689\u201393. https:\/\/doi.org\/10.1002\/1097-0142(20010915)92:6+%3C1689::aid-cncr1498%3E3.0.co;2-h.","journal-title":"Cancer"},{"issue":"6","key":"1697_CR134","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/PHM.0000000000000883","volume":"97","author":"RO Bueno de Souza","year":"2018","unstructured":"Bueno de Souza RO, Marcon LF, Arruda ASF, Pontes Junior FL, Melo RC. Effects of mat pilates on physical functional performance of older adults: A Meta-analysis of randomized controlled trials. Am J Phys Med Rehabil. 2018;97(6):414\u201325. https:\/\/doi.org\/10.1097\/PHM.0000000000000883.","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"1697_CR135","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/1534735413485418","volume":"12","author":"RA Campo","year":"2013","unstructured":"Campo RA, O\u2019Connor K, Light KC, Nakamura Y, Lipschitz DL, LaStayo PC, et al. Feasibility and acceptability of a Tai Chi Chih randomized controlled trial in senior female cancer survivors. Integr Cancer Ther. 2013;12(6):464\u201374. https:\/\/doi.org\/10.1177\/1534735413485418.","journal-title":"Integr Cancer Ther"},{"issue":"3","key":"1697_CR136","doi-asserted-by":"publisher","first-page":"CD012681","DOI":"10.1002\/14651858.CD012681.pub2","volume":"3","author":"S van Deuren","year":"2020","unstructured":"van Deuren S, Boonstra A, van Dulmen-den Broeder E, Blijlevens N, Knoop H, Loonen J. Severe fatigue after treatment for childhood cancer. Cochrane Database Syst Rev. 2020;3(3):CD012681. https:\/\/doi.org\/10.1002\/14651858.CD012681.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1697_CR137","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.bbi.2007.03.013","volume":"21","author":"JE Bower","year":"2007","unstructured":"Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun. 2007;21(7):863\u201371. https:\/\/doi.org\/10.1016\/j.bbi.2007.03.013.","journal-title":"Brain Behav Immun"},{"issue":"8","key":"1697_CR138","doi-asserted-by":"publisher","first-page":"792","DOI":"10.6004\/jnccn.2023.0041","volume":"21","author":"T Sanft","year":"2023","unstructured":"Sanft T, Day A, Ansbaugh S, Armenian S, Baker KS, Ballinger T, et al. NCCN Guidelines(R) insights: survivorship, version 1.2023. J Natl Compr Canc Netw. 2023;21(8):792\u2013803. https:\/\/doi.org\/10.6004\/jnccn.2023.0041.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"1697_CR139","first-page":"415","volume":"29","author":"T Hsu","year":"2011","unstructured":"Hsu T, Ennis M, Hood N, Graham M, Goodwin P. Quality of life in long-term breast cancer survivors. J Clin Oncol. 2011;29(4):415\u201322.","journal-title":"J Clin Oncol"},{"key":"1697_CR140","doi-asserted-by":"publisher","unstructured":"Bower JE, Lamkin DM. Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun. 2013;30(S0):S48\u201357. https:\/\/doi.org\/10.1016\/j.bbi.2012.06.011.","DOI":"10.1016\/j.bbi.2012.06.011"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01697-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01697-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01697-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:12:08Z","timestamp":1757185928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01697-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":140,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01697-9","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"29 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}